OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
General Information	759
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19	330
Keep Gimmicks of Toy E-Cigarettes Away and Juveniles on Track Towards the Tobacco Endgame	272
Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis	271
General Information	182
ANGIOTENSIN II: A SALVAGE THERAPY IN CATECHOLAMINE-RESISTANT VASODILATORY SHOCK DUE TO CALCIUM CHANNEL BLOCKERS AND ACE INHIBITORS OVERDOSE	178
Response	167
Response	155
General Information	136
A 51-Year-Old Man With Dyspnea and a Pulmonary Nodule	126
The Proton Is Not Enough	124
Attic of Sorrow	99
A 36-Year-Old Patient With Crohn Disease and Bilateral Pleural Effusions	98
“Suction vs Gravity: A Distinction Without a Difference?”	97
Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP	96
Psychiatric Outcomes in ICU Patients With Family Visitation	93
A Mediastinal Mass in a Middle-Aged Woman From a Rare Cause	91
Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis	87
Pulmonary Artery Calcification in a 57-Year-Old Man	87
INFLUENCE OF EXPEDITED MECHANICAL THROMBECTOMY ON OUTCOMES IN ACUTE PULMONARY EMBOLISM: FLASH REGISTRY INSIGHTS	87
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab	83
Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019	82
COUNTERPOINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? No	82
Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk	80
Clinician- and Patient-Identified Solutions to Reduce the Fragmentation of Post-ICU Care in Australia	80

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	79
Developing and Validation of a Multimodal-Based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia	78
WITHDRAWN	75
Rebuttal From Dr Keir and Prof Chalmers	74
WITHDRAWN	73
HEMOTHORAX SECONDARY TO THORACIC ENDOMETRIOSIS	70
KETAMINE TO ASSIST VENTILATOR WEANING AND EXTUBATION IN PATIENTS WHO FAIL SBT FROM SEVERE AGITATION AND ANXIETY	68
DISSEMINATED CRYPTOCOCCAL INFECTION AFTER INITIATION OF BENRALIZUMAB IN A PATIENT WITH ASYMPTOMATIC PULMONARY CRYPTOCOCCUS	68
COVID-ASSOCIATED PULMONARY FIBROSIS: SUBPLEURAL SPARING DISTANCE AS A DISTINGUISHING FEATURE COMPARED TO NON-COVID NONSPECIFIC INTERSTITIAL PNEUMONIA	66
TURNING OF THE TIDES, WHEN BENIGN BECOMES MALIGNANT: A CASE OF LARGE FIBROUS TUMOR OF THE LUNG	65
MASSIVE EMPYEMA SECONDARY TO STREPTOCOCCUS CONSTELLATUS INFECTION	65
THE CASCADING EFFECT: A RARE CASE OF EPINEPHRINE-INDUCED CORONARY ARTERY VASOSPASM	65
A CHALLENGING DIAGNOSIS OF MULTIPLE PULMONARY NODULES IN AN IMMUNOSUPPRESSED PATIENT WITH APLASTIC ANEMIA WITH CYTOPENIAS: A CASE REPORT	63
Monitoring Biologic Therapy in Asthma Using Functional Imaging	62
PROCEDURAL GUIDANCE FOR EXTRACORPOREAL MEMBRANE OXYGENATION WITH TRANSESOPHAGEAL ULTRASOUND	62
A CASE OF AN ATYPICAL ENDOBROCHIAL LESION	62
AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS	62
WHEN YOU HEAR HOOFBEATS, PREPARE FOR ZEBRAS: A CASE OF SARCOMATOID CARCINOMA	61
WITHDRAWN	61
ISCHEMIC CEREBROVASCULAR SYNDROME, THE DEBUT OF A NEPHROTIC SYNDROME	59
PATHOPHYSIOLOGY OF LACTIC ACIDOSIS IN PATIENTS WITH ASTHMA	59
NONISCHEMIC CARDIOMYOPATHY AND CARDIAC ARREST ATTRIBUTABLE TO ANABOLIC-ANDROGENIC STEROIDS	59
UNUSUAL COMPLICATIONS OF PSEUDOMONAS AERUGINOSA INFECTION IN A CYSTIC FIBROSIS PATIENT	59
OBSTRUCTIVE LUNG DISEASE CONCORDANCE/DISCORDANCE WHEN COMPARING TWO PREDICTIVE EQUATIONS (GLI VS CRAPO/MORRIS)	58
STREPTOCOCCUS AGALACTIAE ENDOCARDITIS OF THE NATIVE VALVE IN THE PATIENT WITH END-STAGE RENAL DISEASE	58
CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB	56
CHANGES IN FRACTION OF EXHALED NITRIC OXIDE WHILE VAPING E-CIGERETTE	56
IBRUTINIB-INDUCED SINUS NODE DYSFUNCTION: A RARE CLINICAL ENTITY	56
A UNIQUE CASE OF GRANULOMATOSIS WITH POLYANGIITIS COMPLICATED BY THROMBOTIC THROMBOCYTOPENIA PURPURA	55
AMINOPHYLLINE: A FORGOTTEN RESCUE AGENT FOR PATIENTS WITH SEVERE COPD EXACERBATION AND RIGHT HEART FAILURE? A CASE REPORT AND REVIEW OF THE LITERATURE	54